Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
MT

WKN: A3CVSY | ISIN: SE0015987904 | Ticker: 99Z
Frankfurt
18.11.26 | 08:02
0,002 Euro
-15,38 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
MODUS THERAPEUTICS HOLDING AB Chart 1 Jahr
5-Tage-Chart
MODUS THERAPEUTICS HOLDING AB 5-Tage-Chart

Aktuelle News zur MODUS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.10.KDventures AB: John Öhd focuses on Modus Therapeutics and continues as Senior Advisor to KDventures183STOCKHOLM, Sweden, October 15, 2026. KDventures AB (publ) (Nasdaq Stockholm: KDV) today announces that John Öhd is transitioning from his role as Chief Scientific Officer (CSO) to Senior Advisor at...
► Artikel lesen
14.10.Modus Therapeutics Holding AB: Modus Therapeutics temporarily pauses enrollment in Phase IIa study of sevuparin in CKD with anemia179Modus Therapeutics Holding AB (publ) ("Modus" or the "Company") today announced that it has voluntarily decided, as a precautionary measure, to temporarily pause enrollment in Part 2 of the ongoing...
► Artikel lesen
MODUS THERAPEUTICS Aktie jetzt für 0€ handeln
26.08.Modus Therapeutics Holding AB: Modus Therapeutics publishes interim report for Q2 2026307STOCKHOLM, SWEDEN - 26 August 2026: Modus Therapeutics Holding AB ("Modus Therapeutics") hereby publishes its interim report for the second quarter of 2026. The report is available on the company's...
► Artikel lesen
28.05.Modus Therapeutics Holding AB: Annual General Meeting in Modus Therapeutics Holding AB (publ)244Modus Therapeutics' Annual General Meeting on 28 May 2026 resolved in accordance with the following: That no dividend would be paid.To discharge the board members and the managing director from liability...
► Artikel lesen
26.05.Modus Therapeutics Holding AB: Modus Therapeutics publishes interim report for Q1 2026262STOCKHOLM, SWEDEN - 26 May 2026: Modus Therapeutics Holding AB ("Modus Therapeutics") hereby publishes its interim report for the first quarter of 2026. The report is available on the company's website...
► Artikel lesen
25.02.Modus Therapeutics Holding AB: Modus Therapeutics publishes year-end report for 2025869STOCKHOLM, SWEDEN - 25 February 2026: Modus Therapeutics Holding AB ("Modus Therapeutics") hereby publishes year-end report for 2025. The report is available on the company's website (www.modustx.com)...
► Artikel lesen
10.12.25Karolinska Development AB (publ): Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia383STOCKHOLM, SWEDEN December 10, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has dosed the first patient in the phase 2a...
► Artikel lesen
26.11.25Modus Therapeutics Holding AB: Modus Therapeutics publishes Interim report for the third quarter 2025592STOCKHOLM, SWEDEN - 26 November 2025: Modus Therapeutics Holding AB ("Modus Therapeutics") hereby publishes an interim report for the third quarter of 2025. The report is available on the company's...
► Artikel lesen
8 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1